Latest Articles
How Sitting For Long Hours At Desk Job Leads To Silent Cancer Risk No One Talks About; Know From Doctor - The Daily Jagran
How Sitting For Long Hours At Desk Job Leads To Silent Cancer Risk No One Talks About; Know From Doctor The Daily Jagran
Published: Feb. 6, 2026, 1:30 p.m.
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings - Oncodaily
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings Oncodaily
Published: Jan. 30, 2026, 5:27 p.m.
Analysis: Aggregate Harms Associated With Use of Alcohol, Tobacco Far Outweigh Cannabis-Related Risks - NORML
Analysis: Aggregate Harms Associated With Use of Alcohol, Tobacco Far Outweigh Cannabis-Related Risks NORML
Published: Jan. 29, 2026, 5:48 p.m.
Ibuprofen may decrease cancer risk - Female First
Ibuprofen may decrease cancer risk Female First
Published: Jan. 23, 2026, 3:16 p.m.
Research Suggests Ibuprofen May Lower Cancer Risk Beyond Pain Relief - SSBCrack News
Research Suggests Ibuprofen May Lower Cancer Risk Beyond Pain Relief SSBCrack News
Published: Jan. 20, 2026, 9:33 a.m.
A common painkiller may be quietly changing cancer risk - ScienceDaily
A common painkiller may be quietly changing cancer risk ScienceDaily
Published: Jan. 20, 2026, 8:49 a.m.
Ruptured Ovarian Endometrioma During Pregnancy: A Case Report and Review Highlighting Clinically Occult Risk Factors - Cureus
Ruptured Ovarian Endometrioma During Pregnancy: A Case Report and Review Highlighting Clinically Occult Risk Factors Cureus
Published: Jan. 19, 2026, 10:24 p.m.
Endometriosis: Is Your Fertility at Risk? - Hackensack Meridian Health
Endometriosis: Is Your Fertility at Risk? Hackensack Meridian Health
Published: Jan. 16, 2026, 4:14 p.m.
Pharmacies Use Technology to Monitor High-Risk Patients During Care Transitions - geneonline.com
Pharmacies Use Technology to Monitor High-Risk Patients During Care Transitions geneonline.com
Published: Jan. 14, 2026, 11:38 a.m.
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post
Published: Jan. 12, 2026, 6:10 p.m.
Link copied to clipboard!